Janpix is a biotechnology company discovering and developing inhibitors to help patients suffering from cancer. It provides a pipeline of STAT (signal transducer and activator of transcription) inhibitors that attack not only the tumor directly, but also modulate immune cells in the vicinity of the tumor to assist with tumor eradication.